<DOC>
	<DOCNO>NCT02254252</DOCNO>
	<brief_summary>Slow coronary flow angiographically diagnose phenomenon define delayed opacification epicardial artery absence significant arterial narrowing blockade . Endothelial dysfunction level microarteries propose main pathological mechanism regard . Available evidence suggest standard anti-angina medication ( e.g . nitroglycerin ) solely target large coronary trunk might provide adequate symptomatic relief patient slow coronary flow phenomenon . It hypothesize anti-angina medication exert vasodilatory effect large coronary artery well small divide branch might superior nitroglycerin amelioration angina symptom . The present randomized clinical trial thus design conduct compare short-term efficacy nicorandil ( dual-acting anti-angina medication effect large small coronary vessel ) nitroglycerin group patient slow coronary flow present frequent angina episode .</brief_summary>
	<brief_title>Effects Nicorandil Angina Symptoms Patients With Coronary Slow Flow</brief_title>
	<detailed_description />
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Nicorandil</mesh_term>
	<mesh_term>Enzyme Inhibitors</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>coronary angiographic study , arterial narrow exceed 50 % three main coronary artery ; ( delay opacification least one main coronary artery document . Delayed opacification defines correct TIMI frame count &gt; 23 fps comorbid cardiovascular condition mild coronary atherosclerosis coronary slow flow refusal participate discontinuation treatment return follow visit</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Slow coronary flow phenomenon</keyword>
	<keyword>Angina pectoris</keyword>
	<keyword>chest pain</keyword>
	<keyword>nicroandil</keyword>
</DOC>